Health and Healthcare Systems
How antimicrobial resistance is risking blood cancer treatment
Antimicrobial resistance threatens blood cancer care, raising infection risks, undermining trials and endangering the future of oncology innovation.
Antimicrobial resistance threatens blood cancer care, raising infection risks, undermining trials and endangering the future of oncology innovation.
Antimicrobial resistance (AMR) threatens lives, healthcare systems and the global economy. But anticipatory governance that reshapes responses can get ahead of the problem
With antimicrobial resistance threatening additional future healthcare costs of $1 trillion, better data would help shore up national action plans.


